Download this Paper Open PDF in Browser

Disparities between Asbestosis and Silicosis Claims Generated By Litigation Screenings and Clinical Studies

111 Pages Posted: 14 Mar 2007 Last revised: 28 Sep 2011

Lester Brickman

Yeshiva University - Benjamin N. Cardozo School of Law

Abstract

In 2005, U.S. District Court Judge Janis Jack, presiding over an MDL proceeding involving 10,000 claims of silicosis, issued a 264 page opinion rejecting the reliability of thousands of medical reports generated by litigation screenings. In that report, she documented in great detail the existence of a fraudulent scheme to create bogus medical evidence that lead her to conclude that it is apparent that truth and justice had very little to do with these diagnoses. . . . [Indeed] it is clear that lawyers, doctors and screening companies were all willing participants in a scheme to manufacture. . . [diagnoses] for money.

In this article, I consider whether hundreds of thousands of medical reports generated by asbestos screenings also have been manufactured for money. While both plaintiffs' lawyers and the litigation doctors they hire have steadfastly refused to disclose the percentage of those screened that are found to have asbestosis, I have been able to determine the percentages of positive diagnoses and to compare that to the results of a review of 80 clinical studies. Based on my research, I conclude that for every 1000 occupationally exposed workers screened, litigation screenings generate approximately 500-600 diagnoses of asbestosis. In a clinical setting, however, the number diagnosed with asbestosis would be 30-50. The excess diagnoses of asbestosis in litigation screenings produced over $25 billion in payments to claimants of which approximately $10 billion was paid to the lawyers.

I also review clinical studies in which X-rays read by litigation doctors were re-read by independent medical experts. These re-readings found error rates that ranged from 62% to 97.5%.

My review of the pandemic of nonmalignant asbestos-related disease claims which were filed in the 1990-2004 period in the tort system and with asbestos bankruptcy trusts and comparison with the number of hospitalizations primarily for asbestosis in that period shows similar disparities.

The conclusion I draw from the data and evidence presented is that Judge Jack's findings with regard to the medical reports in the silica MDL applies with at least equal force to nonmalignant asbestos litigation: the medical reports are mostly manufactured for money.

Keywords: Asbestosis, silicosis, litigation screenings, Judge Janis Jack, MDL1553, manufactured for money, asbestos litigation, silica litigation, pulmonary function tests

JEL Classification: G33, K13, K41

Suggested Citation

Brickman, Lester, Disparities between Asbestosis and Silicosis Claims Generated By Litigation Screenings and Clinical Studies. Cardozo Law Review, Vol. 29, No. 2, 2007; Cardozo Legal Studies Research Paper No. 192. Available at SSRN: https://ssrn.com/abstract=970993

Lester Brickman (Contact Author)

Yeshiva University - Benjamin N. Cardozo School of Law ( email )

55 Fifth Ave.
New York, NY 10003
United States
212-790-0327 (Phone)
212-790-0205 (Fax)

Paper statistics

Downloads
790
Rank
25,198
Abstract Views
5,091